Current Edition

Comparison of Regulatory Process of COVID-19 Vaccines; Between Emerging Markets, EU

Coronavirus disease, COVID-19, has affected all of our lives greatly since the end of 2019. We have faced experiences that we have never come across before. We need to take precautions because this infectious disease spreads through droplets of saliva or discharge from the nose when an infected person coughs or sneezes. Pelin Boran at Pelin Boran Regulatory Affairs Solutions & Consultancy discusses that all the data on quality, safety, immunogenicity and efficacy should comply with the standards and criteria, both country-specific and from a global perspective.